Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

146

...

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L01XX41	HALAVEN	B	Eribulin mesylate - 0.88mg/2ml	0.88mg/2ml	Injectable solution	35,421,768 L.L
L01XX41	HALAVEN	B	Eribulin mesylate - 0.88mg/2ml	0.88mg/2ml	Injectable solution	L.L
N04BC05	SIFROL	B	Pramipexole (dihydrochloride monohydrate) - 0.7mg	0.7mg	Tablet	2,478,046 L.L
N04BC05	PRAMIPEXOLE BIOGARAN	G	Pramipexole (dihydrochloride monohydrate) - 0.7mg	0.7mg	Tablet	1,733,557 L.L
R05CA12	IVYMUC	G	Dried Ivy leaf extract - 0.7g/100ml	0.7g/100ml	Syrup	300,765 L.L
R05CA12	TOUCALM	G	Dried Ivy leaf extract - 0.7g/100ml	0.7g/100ml	Syrup	300,765 L.L
M09AX10	EVRYSDI	B	Risdiplam - 0.75mg/ml	0.75mg/ml	Powder	865,644,067 L.L
M09AX10	EVRYSDI	B	Risdiplam - 0.75mg/ml	0.75mg/ml	Powder	L.L
A10BJ05	TRULICITY	BioTech	Dulaglutide - 0.75mg/0.5ml	0.75mg/0.5ml	Injectable solution	10,165,201 L.L
L04AA18	CERTICAN	B	Everolimus - 0.75mg	0.75mg	Tablet	26,832,962 L.L
L04AA18	CERTICAN	B	Everolimus - 0.75mg	0.75mg	Tablet	L.L
N04BC05	SIFROL ER	B	Pramipexole (dihydrochloride monohydrate) - 0.75mg	0.75mg	Tablet, extended release	942,034 L.L
D06BX01	ROZEX	B	Metronidazole - 0.75g/100g	0.75%	Gel	584,571 L.L
H01CB05	SIGNIFOR	B	Pasireotide (diaspartate) - 0.6mg/ml	0.6mg/ml	Injectable solution	187,497,407 L.L
G03CA03	OESTRACLIN	G	Estradiol - 0.6mg/g	0.6mg/g	Gel	448,843 L.L
D02AX	BIAFINE	B	Trolamine - 0.67g/100g	0.67g/100g	Emulsion	524,099 L.L
J07BC02	HEALIVE-HEPATITIS A VACCINE (HUMAN DIPLOID CELL) INACTIVATED	BioTech	Hepatitis A, inactivated antigen (TZ84 Strain), human diploid cell - 0.5ml/dose	0.5ml/dose	Injectable suspension	1,777,904 L.L
J07BC02	HEALIVE-HEPATITIS A VACCINE (HUMAN DIPLOID CELL) INACTIVATED	BioTech	Hepatitis A, inactivated antigen (TZ84 Strain), human diploid cell - 1ml/dose	0.5ml/dose	Injectable suspension	2,257,655 L.L
R01AA05	UTABON	G	Oxymetazoline HCl - 0.5mg/ml	0.5mg/ml	Spray, solution	302,365 L.L
R06AE09	CALIVIDA	G	Levocetirizine dihydrochloride - 0.5mg/ml	0.5mg/ml	Solution	1,158,264 L.L
R06AE09	ZOLICIN	G	Levocetirizine dihydrochloride - 0.5mg/ml	0.5mg/ml	Solution	663,858 L.L
R06AX27	RINA 5	G	Desloratadine - 5mg	0.5mg/ml	Tablet, film coated	134,384 L.L
R06AX27	AERIUS	B	Desloratadine - 0.5mg/ml	0.5mg/ml	Solution	403,153 L.L
R06AX27	AERIALLERG	G	Desloratadine - 0.5mg/ml	0.5mg/ml	Syrup	200,233 L.L
R06AX27	DELINE	G	Desloratadine - 0.5mg/ml	0.5mg/ml	Syrup	197,097 L.L
R06AX27	DELINE-MED	G	Desloratadine - 0.5mg/ml	0.5mg/ml	Syrup	259,810 L.L
R06AX27	DESLAMED	G	Desloratadine - 0.5mg/ml	0.5mg/ml	Solution	323,802 L.L
R06AX27	DESLOR CHAPHA	G	Desloratadine - 0.5mg/ml	0.5mg/ml	Solution	323,802 L.L
R06AX27	DESLORATADINE ARROW	G	Desloratadine - 0.5mg/ml	0.5mg/ml	Solution	256,674 L.L
R06AX27	ORADUS	G	Desloratadine - 0.5mg/ml	0.5mg/ml	Solution	199,657 L.L

...

146

...